[1] L MANARA. Functional identification of rat atypical beta-adrenoceptors by the first beta 3-selective antagonists, aryloxypropanolaminotetralins.[J]. British Journal of Pharmacology, 1996, 117 3: 435-442. DOI:
10.1111/j.1476-5381.1996.tb15209.x[2] C HOFFMANN. Comparative pharmacology of human beta-adrenergic receptor subtypes–characterization of stably transfected receptors in CHO cells.[J]. Naunyn-Schmiedeberg’s archives of pharmacology, 2004, 369 2: 151-159. DOI:
10.1007/s00210-003-0860-y[3] SOTIRIA BEXIS James R D. Role of α1- and β3-adrenoceptors in the modulation by SR59230A of the effects of MDMA on body temperature in the mouse[J]. British Journal of Pharmacology, 2009, 158 1: 259-266. DOI:
10.1111/j.1476-5381.2009.00186.x[4] K. MIZUNO. Stimulation of β3‐adrenoceptors causes phosphorylation of p38 mitogen‐activated protein kinase via a stimulatory G protein‐dependent pathway in 3T3‐L1 adipocytes[J]. British Journal of Pharmacology, 2002, 135 1. DOI:
10.1038/sj.bjp.0704537[5] RUN-TAO GAN. Chronic blocking of β3-adrenoceptor ameliorates cardiac function in rat model of heart failure[J]. Chinese Medical Journal, 2007, 120 1: 2250-2255. DOI:
10.1097/00029330-200712020-00018